On this page
Mepsevii
vestronidase alfa-vjbk
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Mepsevii
Proper name
vestronidase alfa-vjbk
Licence type
351(a)
BLA number
761047
Applicant
Ultragenyx Pharamceutical Inc.
Center
CDER
Presentations
1
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 10MG/5ML (2MG/ML) | Injection | Intravenous | Single-Dose Vial | Rx | November 15, 2017 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | November 15, 2024 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |